Future of Miniature Medical Devices and Portable Health Care
Compact technology improves how physicians monitor and treat patients. Learn about the future of miniature medical devices and portable health ...
Effective Tips for Cleaning Up Family Sick Messes
Dealing with sick family members at home and the messes that come with it? Learn effective tips for cleaning your ...
The Quiet Revolution in the Exam Room: AI Tools That Change Work, Not Headlines
The electronic health record did not break medicine’s intellect. It broke its time. Documentation expanded, inboxes multiplied, and clinicians began ...
Wearables Are Becoming Clinical Instruments. AI Is the Engine.
A decade ago, a smartwatch was a pedometer with ambitions. Today, wearables are producing physiologic traces that clinicians recognize as ...
GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.
A prescription class once framed as a vanity shortcut has become a serious cardiometabolic instrument, and the public conversation still ...
The Second Reader That Never Sleeps: Large Language Models and Clinical Decision-Making
The model is already in the workflow A quiet fact of 2026 is that many clinicians are using large language ...
When Patients Bring a Co-Pilot to the Exam Room: Large Language Models and the New Shape of Patient Empowerment
The patient has a new private tool A patient can now interrogate a medical claim as quickly as they can ...
The Paper Trail Problem: LLMs, Clinical Care, and the Coming Reckoning in Legal Liability
The future lawsuit will be built from metadata The most consequential question about LLMs in healthcare is not whether they ...
The Unsettled Future of Consumer Medicine
Healthcare consumerism introduces a set of unresolved tensions that resist simple resolution. Efficiency and equity, often presented as complementary goals, ...
Convenience as Clinical Infrastructure
Digital access has quietly redefined what patients consider acceptable care. Expectations around timeliness, availability, and responsiveness have shifted decisively, not ...
Why Investors Now Care About Patient Experience
Investor interest in healthcare increasingly tracks patient experience and retention rather than raw utilization growth. This shift was evident across ...
The Retrieval Turn: RAG, LLMs, and the Next Generation of Clinical Generative AI
The core problem: language models are persuasive even when they are guessing Large language models excel at producing coherent text ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more